Grading of Solicited systemic reactogenicity adverse events (AEs);Geometric Mean Titer (GMT) of the serum neutralizing antibody (NAb) response to SARS-CoV-2 virus;Frequency of Solicited local reactogenicity adverse events (AEs);Geometric Mean Titer (GMT) of the serum antibody response;Serious adverse events (SAEs), Medically attended adverse events (MAAEs) and any Adverse events (AEs) leading to study withdrawal at any time during the study;Frequency of Solicited systemic reactogenicity adverse events (AEs);Unsolicited adverse events (AEs);Grading of Solicited local reactogenicity adverse events (AEs)

Grading of Solicited systemic reactogenicity adverse events (AEs);Geometric Mean Titer (GMT) of the serum neutralizing antibody (NAb) response to SARS-CoV-2 virus;Frequency of Solicited local reactogenicity adverse events (AEs);Geometric Mean Titer (GMT) of the serum antibody response;Serious adverse events (SAEs), Medically attended adverse events (MAAEs) and any Adverse events (AEs) leading to study withdrawal at any time during the study;Frequency of Solicited systemic reactogenicity adverse events (AEs);Unsolicited adverse events (AEs);Grading of Solicited local reactogenicity adverse events (AEs)